Interest heats up in gastrointestinal space.
Sheridan
Cormac
C
D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy* / Q000191:economics; D015195:Drug Design; D017850:Economics, Pharmaceutical / Q000639:trends*; D005765:Gastrointestinal Agents / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D043183:Irritable Bowel Syndrome / Q000188:drug therapy* / Q000191:economics
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab